Verition Fund Management
MRNA icon

Verition Fund Management’s Moderna MRNA Stock Holding History

Verition Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-452,529
Closed -$13.3M – 3087
2025
Q4 		$13.3M Buy
452,529
+230,192
+104% +$6.25M 0.05% 332
2025
Q3 		$5.74M Sell
222,337
-6,078
-3% -$170K 0.02% 1003
2025
Q2 		$6.3M Buy
228,415
+114,347
+100% +$3.01M 0.03% 890
2025
Q1 		$3.23M Buy
114,068
+4,649
+4% +$165K 0.02% 1215
2024
Q4 		$4.55M Buy
109,419
+70,803
+183% +$3.38M 0.02% 953
2024
Q3 		$2.58M Buy
38,616
+19,538
+102% +$1.79M 0.01% 1268
2024
Q2 		$2.27M Sell
19,078
-8,921
-32% -$1.13M 0.01% 1191
2024
Q1 		$2.98M Buy
27,999
+11,057
+65% +$1.11M 0.02% 992
2023
Q4 		$1.68M Buy
+16,942
New +$1.42M 0.01% 926
2023
Q2 		– Sell
-9,400
Closed -$1.44M – 2415
2023
Q1 		$1.44M Sell
9,400
-130
-1% -$21.4K 0.02% 809
2022
Q4 		$1.71M Sell
9,530
-3,582
-27% -$586K 0.03% 678
2022
Q3 		$1.55M Buy
13,112
+9,676
+282% +$1.47M 0.02% 1084
2022
Q2 		$490K Sell
3,436
-4,908
-59% -$702K 0.01% 1464
2022
Q1 		$1.44M Buy
8,344
+3,863
+86% +$650K 0.02% 1215
2021
Q4 		$1.14M Buy
4,481
+2,753
+159% +$805K 0.01% 1210
2021
Q3 		$665K Buy
1,728
+793
+85% +$292K 0.01% 1100
2021
Q2 		$220K Sell
935
-3,024
-76% -$540K ﹤0.01% 1531
2021
Q1 		$518K Sell
3,959
-8,703
-69% -$1.26M 0.01% 850
2020
Q4 		$1.32M Buy
+12,662
New +$1.28M 0.01% 453
2020
Q3 		– Sell
-20,715
Closed -$1.33M – 1266
2020
Q2 		$1.33M Buy
+20,715
New +$1.13M 0.04% 322

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verition Fund Management's MRNA Position: Q1 2026 in Review

Verition Fund Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 452,529 shares — an estimated $13.3M sold.

Verition Fund Management first reported a position in MRNA in Q2 2020 and held it in 20 quarters. The position peaked at $13.3M in Q4 2025. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Verition Fund Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 452,529 Moderna shares in Q1 2026, an estimated $13.3M.
  • Verition Fund Management first reported a position in Moderna in Q2 2020 and held it in 20 quarters.
  • Verition Fund Management's Moderna position peaked at $13.3M in Q4 2025.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.